Scinai Immunotherapeutics (SCNI.US) gained to $0.8214, up +80.13% intraday, with a 5-minute gain exceeding 3% at one point.
The biopharmaceutical company surged after announcing the completion of a $2.61 million private placement. For small-cap biotech names, such financing announcements frequently trigger sharp short-term price moves as trading volume spikes. No additional clinical or regulatory catalysts have been disclosed alongside the financing; the move appears primarily driven by the immediate market reaction to the capital raise.